Condensed Consolidated Financial Statement Detail (Details)
|
3 Months Ended | 9 Months Ended | 1 Months Ended | 9 Months Ended | 1 Months Ended | 9 Months Ended | 1 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2014
USD ($)
|
Sep. 30, 2013
USD ($)
|
Sep. 30, 2014
USD ($)
|
Sep. 30, 2013
USD ($)
|
Dec. 31, 2013
USD ($)
|
Mar. 31, 2012
Five year warrants issued in March 2012 [Member]
USD ($)
|
Sep. 30, 2014
Five year warrants issued in March 2012 [Member]
USD ($)
|
Sep. 30, 2014
Five year warrants issued in March 2012 [Member]
|
Dec. 31, 2013
Five year warrants issued in March 2012 [Member]
USD ($)
|
Mar. 31, 2012
Five year warrants issued in March 2012 [Member]
|
Feb. 28, 2010
Five year warrants issued in February 2010 [Member]
USD ($)
|
Sep. 30, 2014
Five year warrants issued in February 2010 [Member]
USD ($)
|
Dec. 31, 2013
Five year warrants issued in February 2010 [Member]
USD ($)
|
Feb. 28, 2010
Five year warrants issued in February 2010 [Member]
|
Jun. 30, 2009
Warrants issued to private investors [Member]
USD ($)
|
Sep. 30, 2014
Warrants issued to private investors [Member]
USD ($)
|
Jun. 30, 2009
Warrants issued to private investors [Member]
|
Sep. 30, 2014
Options Contract [Member]
USD ($)
Contract
|
Sep. 30, 2013
Options Contract [Member]
USD ($)
|
Sep. 30, 2014
Options Contract [Member]
USD ($)
Contract
|
Sep. 30, 2013
Options Contract [Member]
USD ($)
|
Sep. 30, 2014
Options Contract [Member]
EUR (€)
|
Sep. 30, 2014
Option Contract 1 [Member]
EUR (€)
|
Sep. 30, 2014
Option Contract 2 [Member]
EUR (€)
|
Sep. 30, 2014
Demand Deposits [Member]
USD ($)
|
Dec. 31, 2013
Demand Deposits [Member]
USD ($)
|
Sep. 30, 2014
Money Market Funds [Member]
USD ($)
|
Dec. 31, 2013
Money Market Funds [Member]
USD ($)
|
Sep. 30, 2014
Common stock options and restricted stock units [Member]
|
Sep. 30, 2013
Common stock options and restricted stock units [Member]
|
Sep. 30, 2014
Common stock options and restricted stock units [Member]
|
Sep. 30, 2013
Common stock options and restricted stock units [Member]
|
Sep. 30, 2014
Warrants for common stock [Member]
|
Sep. 30, 2013
Warrants for common stock [Member]
|
Sep. 30, 2014
Warrants for common stock [Member]
|
Sep. 30, 2013
Warrants for common stock [Member]
|
||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||||||||||||||||||||||||||||||||||||||
Antidilutive securities excluded from computation of earnings per share (in shares) | 9,948,000 | 22,795,000 | 8,511,000 | 22,123,000 | 8,037,000 | 6,825,000 | 6,601,000 | 6,017,000 | 1,910,000 | 15,970,000 | 1,910,000 | 16,106,000 | |||||||||||||||||||||||||||
Numerator [Abstract] | |||||||||||||||||||||||||||||||||||||||
Net loss before taxes, Basic | $ (14,399,000) | $ (29,639,000) | $ (30,983,000) | $ (71,774,000) | |||||||||||||||||||||||||||||||||||
Adjustment for revaluation of contingent warrant liabilities | 5,360,000 | 32,510,000 | |||||||||||||||||||||||||||||||||||||
Net loss before taxes, Diluted | (19,759,000) | (63,493,000) | |||||||||||||||||||||||||||||||||||||
Denominator Abstract] | |||||||||||||||||||||||||||||||||||||||
Weighted average shares outstanding used for basic net loss per share (in shares) | 107,208,000 | 87,033,000 | 106,768,000 | 84,205,000 | |||||||||||||||||||||||||||||||||||
Effect of dilutive warrants (in shares) | 7,115,000 | 8,108,000 | |||||||||||||||||||||||||||||||||||||
Weighted average shares outstanding and dilutive securities used for diluted net income per share (in shares) | 114,323,000 | 87,033,000 | 114,876,000 | 84,205,000 | |||||||||||||||||||||||||||||||||||
Cash and Cash Equivalents [Line Items] | |||||||||||||||||||||||||||||||||||||||
Cash equivalents | 19,500,000 | 18,900,000 | 34,600,000 | 82,800,000 | |||||||||||||||||||||||||||||||||||
Short-term Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||
Short-term investments, U.S. treasury securities | 5,000,000 | 5,000,000 | 19,990,000 | ||||||||||||||||||||||||||||||||||||
Derivative [Line Items] | |||||||||||||||||||||||||||||||||||||||
Notional amount of derivative liability | 15,000,000 | ||||||||||||||||||||||||||||||||||||||
Number of foreign exchange option contracts | 2 | 2 | |||||||||||||||||||||||||||||||||||||
Derivative, amount of hedged item | 1,500,000 | 15,000,000 | |||||||||||||||||||||||||||||||||||||
Derivative, premiums | 1,500,000 | ||||||||||||||||||||||||||||||||||||||
Derivative fair value | 100,000 | 100,000 | |||||||||||||||||||||||||||||||||||||
Derivative, loss | 100,000 | 300,000 | 200,000 | ||||||||||||||||||||||||||||||||||||
Derivative, gain | 7,000 | ||||||||||||||||||||||||||||||||||||||
Accrued liabilities [Abstract] | |||||||||||||||||||||||||||||||||||||||
Accrued payroll and other benefits | 2,928,000 | 2,928,000 | 3,009,000 | ||||||||||||||||||||||||||||||||||||
Accrued management incentive compensation | 3,187,000 | 3,187,000 | 4,386,000 | ||||||||||||||||||||||||||||||||||||
Other | 1,388,000 | 1,388,000 | 2,539,000 | ||||||||||||||||||||||||||||||||||||
Total | 7,503,000 | 7,503,000 | 9,934,000 | [1] | |||||||||||||||||||||||||||||||||||
Class of Warrant or Right [Line Items] | |||||||||||||||||||||||||||||||||||||||
Warrant Term | 5 years | 5 years | 5 years | ||||||||||||||||||||||||||||||||||||
Warrants outstanding (in shares) | 12,109,418 | 14,834,577 | 1,260,000 | 347,826 | |||||||||||||||||||||||||||||||||||
Exercise price (in dollars per share) | $ 1.76 | $ 10.50 | $ 19.50 | ||||||||||||||||||||||||||||||||||||
Fair value of warrant liability | 33,700,000 | 68,700,000 | 1,200,000 | 0 | |||||||||||||||||||||||||||||||||||
Gain (loss) on revaluation of warrant liability | 32,500,000 | 1,200,000 | |||||||||||||||||||||||||||||||||||||
Reclassification of warrant liability to equity | $ 2,500,000 | ||||||||||||||||||||||||||||||||||||||
|